Technology

Why Do Only Some Gastric Tumors Respond to Therapy?

Tumors from patients with gastric cancer can be divided into subgroups, based on their gene expression pattern. This information can be used to select the best treatment, according to Patrick Tan and colleagues in the August issue of Gastroenterology. Gastric tumors have large, inter-individual differences in aggressiveness, histopathology features, and

Read more

Fluid Resuscitation for Acute Pancreatitis—When and With What?

Patients that are given fluid resuscitation within 24 hours of developing acute pancreatitis are less likely to experience systemic inflammatory response (SIR) or organ failure, according to a study by Matthew G. Warndorf et al. in the August issue of Clinical Gastroenterology and Hepatology. Acute pancreatitis is an inflammatory process

Read more

Constipation Relief

The drug bisacodyl is effective against chronic constipation and improves patients’ quality of life, according to a large study published by Michael Kamm et al. in the July issue of Clinical Gastroenterology and Hepatology. Constipation affects 12% to 19% of Americans; its prevalence increases with age and it affects women

Read more

Dangerous Diabetes Drugs?

The drugs sitagliptin and exenatide, used to treat patients with type 2 diabetes, increase risk for pancreatitis and cancer, according to a study from Michael Elashoff and colleagues published in the July issue of Gastroenterology. The authors examined the United States (US) Food and Drug Administration’s database of reported adverse

Read more

Treatment for Gallstones?

Cholesterol gallstone disease might be treated with activators of the pregnane X receptor (PXR) such as St. John’s Wort, according to a study in the June issue of Gastroenterology. Cholesterol gallstone disease is caused by a biochemical imbalance of lipids and bile salts in the gallbladder bile. Jinhan He et

Read more

Does Mucosal Healing Determine Which Patients Will Recover From Ulcerative Colitis?

Lack of mucosal healing, based on endoscopic analysis, identifies patients with ulcerative colitis (UC) who are not likely to respond to corticosteroid therapy, according to Sandro Ardizzone et al. in the June issue of Clinical Gastroenterology and Hepatology. In a prospective study, Ardizzone et al. followed 157 patients with moderate

Read more

Tracking Crohn’s Therapy

Measuring blood levels of C-reactive protein (CRP), a marker of inflammation, is a good way to monitor recovery from Crohn’s disease (CD) in patients being treated with infliximab, according to Matthias Jürgens et al. in the May issue of Clinical Gastroenterology and Hepatology. CRP is a protein released into the blood

Read more

H Pylori—Are They Gone Yet?

Helicobacter pylori infection can be treated with proton pump inhibitors (PPIs) and antibiotics, but physicians need ways to determine if the bacteria are completely eradicated months later. In the May issue of Clinical Gastroenterology and Hepatology, Luigi Gatta et al. describe a simple blood test that can detect H pylori

Read more

Colon Complications from Anti-Inflammatory Drugs?

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are known to cause stomach problems, but a large prospective study by Lisa Strate et al. in the May issue of Gastroenterology shows that they can also damage the colon, causing diverticulitis and diverticular bleeding. Strate et al. tracked the use of aspirin,

Read more

What is the Best Strategy for Children with Celiac Disease?

Most children with potential celiac disease, based on serologic markers, remain healthy after 3 years—only about a third develop villous atrophy, report Antonella Tosco et al. in the April issue of Clinical Gastroenterology and Hepatology. However, antibody tests can identify children at greatest risk for the changes in the intestinal

Read more